Staff Scientist II
Stephanie’s current research focus is in developing novel gene edited cell lines for study as a part of the Gene Editing Institute’s Genome Customization Group. Her research interests lie in leveraging the strengths of gene editing for clinical applications, especially within the field of oncology. She received her B.S. from the University of Delaware in 2017, where she studied multi-sensory integration of visual and tactile stimuli using fMRI technology.